Manufacturer record
Hygeia Pharmaceuticals MFG. (P) Ltd. 608: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Hygeia Pharmaceuticals MFG. (P) Ltd. 608 were declared Not of Standard Quality in January 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: DPD030, Levosalbutamol, Guaiphenesin & Ambroxol (Duvent- PD) (exp Nov 2026). CDL Kolkata (CDSCO lab) found it not of standard quality: Assay/content of Levosalbutamol & Ambroxol Hydrochloride. Listed in the January 2024 alert.
Records by type
2 records linked to Hygeia Pharmaceuticals MFG. (P) Ltd. 608 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Levosalbutamol, Guaiphenesin & Ambroxol (Duvent- PD) | Batch DPD030Mfg Dec 2023 · Exp Nov 2026 | Assay/content of Levosalbutamol & Ambroxol HydrochlorideAssay | CDL KolkataCDSCO lab | Jan 2024 |
| Levosalbutamol, Ambroxol & Guaiphenesin Syrup (Bromex - LS Expectorant) | Batch BXE064Mfg Dec 2023 · Exp Nov 2026 | Assay/content of 'Levosalbutamol'Assay | CDL KolkataCDSCO lab | Jan 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.